Karim Alavi to Neoadjuvant Therapy
This is a "connection" page, showing publications Karim Alavi has written about Neoadjuvant Therapy.
Connection Strength
0.278
-
Donovan KF, Tomada EP, Carmichael H, Ricardo A, Berger N, Bonaccorso A, Alavi K, Zaghiyan K, Pigazzi A, Sands D, DeBeche-Adams T, Chadi SA, McLemore EC, Marks JH, Maykel JA, Shawki SF, Steele SR, Albert M, Whiteford MH, Wexner SD, Sylla P. Impact of neoadjuvant treatment on functional outcomes after transanal total mesorectal excision (taTME)-a case series. Surg Endosc. 2025 Oct; 39(10):6802-6812.
Score: 0.233
-
Davids JS, Alavi K, Andres Cervera-Servin J, Choi CS, Sturrock PR, Sweeney WB, Maykel JA. Routine preoperative restaging CTs after neoadjuvant chemoradiation for locally advanced rectal cancer are low yield: a retrospective case study. Int J Surg. 2014 Dec; 12(12):1295-9.
Score: 0.028
-
Gaertner WB, Hagerman GF, Finne CO, Alavi K, Jessurun J, Rothenberger DA, Madoff RD. Fistula-associated anal adenocarcinoma: good results with aggressive therapy. Dis Colon Rectum. 2008 Jul; 51(7):1061-7.
Score: 0.018